Administrative Supplement to Proinsulin ER Export and Beta Cell ER Homeostasis in Health and Diabetes (1R01DK110314)
健康和糖尿病中胰岛素原 ER 输出和 Beta 细胞 ER 稳态的行政补充 (1R01DK110314)
基本信息
- 批准号:10318441
- 负责人:
- 金额:$ 6.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministrative SupplementAffectAnimal ModelApoptosisBeta CellBiogenesisBiological AssayCapsid ProteinsCell DeathCell LineCell SurvivalCell physiologyCessation of lifeChronicCoated vesicleCoupledDefectDevelopmentDiabetes MellitusDiabetic mouseEndoplasmic ReticulumEnvironmentEnzymesEquilibriumFailureFunctional disorderGene ExpressionGenesGeneticGlucoseGolgi ApparatusHealthHomeostasisHumanImpairmentIn VitroIndividualInsulinInsulin-Dependent Diabetes MellitusIslet CellKnowledgeLipidsManuscriptsMembraneMolecularMolecular ChaperonesMonitorNon-Insulin-Dependent Diabetes MellitusOrganellesPathogenesisPathway AnalysisPathway interactionsPhysiologicalPlayPositioning AttributePreparationProcessProductionProinsulinProtein BiosynthesisProtein Export PathwayProteinsProteomicsPublicationsResearchRodentRoleSolidStructure of beta Cell of isletSystems BiologyTechniquesTestingTimeToxic effectUnited StatesVesicleWestern Blottingdiabeticdiabetogenicendoplasmic reticulum stressgenome wide association studyheat-shock proteins 40immunocytochemistryimprovedinnovationisletnovelnovel therapeutic interventionpandemic diseaseprotein complexprotein foldingproteostasispublic health relevancequantitative imaging
项目摘要
PROJECT SUMMARY
Up to date, most of the diabetes-associated genes identified in genome-wide association studies are
enriched in the pancreatic beta cells. Beta cell failure plays a central role in the development and
progression of type 2 diabetes (T2D). The endoplasmic reticulum (ER) is a central organelle for the
massive production and processing of proinsulin. ER homeostasis is critical for normal beta cell
function and is maintained by the delicate balance between protein synthesis, folding, export and
degradation. In contrast, the disruption of ER homeostasis, by many genetic and environmental
diabetes-causing factors, induces ER stress and causes beta cell death in T2D. Compared to our
knowledge in protein synthesis, folding and degradation in beta cell ER, the role of ER export in
proinsulin biogenesis and ER homeostasis is much less understood. This proposal addresses this
knowledge gap. We have obtained strong preliminary results demonstrating that ER exit of proinsulin
requires COPII (coat protein complex II) coated vesicles and defective COPII dependent ER export
strongly induces ER stress. In addition to our results, evidence has recently begun to emerge that
reduced ER-Golgi transport is causative to lipotoxicity-induced ER stress in beta cells. On the basis of
these novel findings, we aim to determine how glucose- and lipid-toxicity affect the ER export of
protein cargo, particularly proinsulin, in beta cells and how defective ER export, in turn, contributes to
ER stress and beta cell dysfunction. Over a thousand proteins, referred to as the proteostasis
network, have been proposed to maintain ER homeostasis. However, to date, only a very small
number of ER proteins have been investigated for their involvement in ER stress or proinsulin
biogenesis in beta cells. A systematic proteomics analysis is needed to comprehensively understand
how different diabetes-causing conditions perturb beta cell ER homeostasis at the onset of T2D. In
this proposal, using systems biology approaches, we will test the central hypothesis that
diabetogenic factors such as glucolipotoxicity disrupt beta cell ER function through perturbing ER
protein homeostasis and COPII dependent ER export. There are two specific aims in this proposal: 1)
Determine how COPII dependent ER export is regulated in health and diabetes; 2) Determine how ER
chaperones and folding enzymes are altered in diabetes and how these changes affect beta cell ER
export. This study will use state-of-the-art quantitative proteomics and other systems biology
approaches to characterize the molecular mechanisms by which diabetes-causing conditions
differentially alter ER homeostasis. The emphasis will be on the ER export, an under-investigated
component of beta cell ER homeostasis.
项目摘要
迄今为止,在全基因组关联研究中鉴定的大多数糖尿病相关基因是
富含胰腺β细胞β细胞衰竭在发育中起着核心作用,
2型糖尿病(T2 D)的进展。内质网(ER)是细胞的中心细胞器,
胰岛素原的大规模生产和加工。ER稳态对正常β细胞至关重要
功能,并通过蛋白质合成,折叠,输出和运输之间的微妙平衡来维持。
降解相反,许多遗传和环境因素对内质网稳态的破坏,
糖尿病致病因子,诱导ER应激并导致T2 D中的β细胞死亡。比起我们
在β细胞ER中的蛋白质合成,折叠和降解方面的知识,
胰岛素原生物合成和ER稳态的研究知之甚少。该提案针对这一点
知识差距。我们已经获得了强有力的初步结果,表明胰岛素原的ER退出
需要COPII(外壳蛋白复合物II)包被的囊泡和有缺陷的COPII依赖性ER输出
强烈诱导ER应激。除了我们的研究结果,最近开始出现的证据表明,
减少的ER-高尔基体转运是β细胞中脂毒性诱导的ER应激的原因。的基础上
这些新的发现,我们的目的是确定如何葡萄糖和脂质毒性影响ER输出的
β细胞中的蛋白质货物,特别是胰岛素原,以及有缺陷的ER输出如何反过来有助于
ER应激和β细胞功能障碍。超过1000种蛋白质,被称为蛋白质稳态
网络,已被提出来维持ER稳态。然而,到目前为止,只有一个非常小的
已经研究了许多ER蛋白参与ER应激或胰岛素原
β细胞的生物合成需要进行系统的蛋白质组学分析,
不同的糖尿病引起的条件如何在T2 D发作时扰乱β细胞ER稳态。在
在这个提议中,我们将使用系统生物学方法来检验中心假设,
致糖尿病因素如糖脂毒性通过干扰ER破坏β细胞ER功能
蛋白质稳态和COPII依赖的ER输出。这项建议有两个具体目标:1)
确定COPII依赖性ER输出如何在健康和糖尿病中调节; 2)确定ER如何
糖尿病中的伴侣蛋白和折叠酶发生改变,以及这些变化如何影响β细胞ER
导出.这项研究将使用最先进的定量蛋白质组学和其他系统生物学
表征糖尿病致病条件的分子机制的方法
差异改变ER稳态。重点将放在ER出口上,这是一个调查不足的问题。
β细胞ER稳态的组成部分。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular architecture of mouse and human pancreatic zymogen granules: protein components and their copy numbers.
- DOI:10.1007/s41048-018-0055-1
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Lee JS;Caruso JA;Hubbs G;Schnepp P;Woods J;Fang J;Li C;Zhang K;Stemmer PM;Jena BP;Chen X
- 通讯作者:Chen X
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuequn Chen其他文献
Xuequn Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuequn Chen', 18)}}的其他基金
Proinsulin ER Export and Beta Cell ER Homeostasis in Health and Diabetes
健康和糖尿病中的胰岛素原 ER 输出和 β 细胞 ER 稳态
- 批准号:
9306076 - 财政年份:2016
- 资助金额:
$ 6.51万 - 项目类别:
Proinsulin ER Export and Beta Cell ER Homeostasis in Health and Diabetes
健康和糖尿病中的胰岛素原 ER 输出和 β 细胞 ER 稳态
- 批准号:
9767125 - 财政年份:2016
- 资助金额:
$ 6.51万 - 项目类别:
Proinsulin ER export and beta cell ER homeostasis in health and diabetes
健康和糖尿病中胰岛素原 ER 输出和 β 细胞 ER 稳态
- 批准号:
9135632 - 财政年份:2015
- 资助金额:
$ 6.51万 - 项目类别:
相似海外基金
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 6.51万 - 项目类别: